The chemical class known as PABPC4L activators encompasses a group of compounds that can influence the activity of the Poly(A) Binding Protein Cytoplasmic 4 Like (PABPC4L). This protein is involved in the intricate processes of mRNA stabilization and translation regulation within the cytoplasm. The compounds that fall under this category are diverse in structure and function, and they can activate PABPC4L by initiating a cascade of events within various cellular pathways. For instance, some activators can engage with cellular signaling mechanisms that modulate the synthesis and assembly of the translation initiation complex, which is central to mRNA translation and, consequently, protein production. Others can alter the cellular environment in a manner that affects mRNA processing and stability, which in turn can modulate the activity of PABPC4L.
In addition to their role in translation regulation, these activators can influence the expression levels of PABPC4L by affecting transcriptional and post-transcriptional mechanisms. Some activators in this class act by modifying the structure of chromatin, thereby regulating gene expression patterns that include the PABPC4L gene. Others can impact the degradation pathways of cellular proteins, which can result in the stabilization of PABPC4L or its associated factors. By affecting these key cellular processes, the activators can play a role in maintaining the proper function of PABPC4L in the cell. The breadth of these compounds' actions reflects the complexity of cellular systems and underscores the multifaceted nature of regulating protein activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Inhibits PDE4, increasing cAMP levels, which could possibly activate PABPC4L by enhancing translation initiation processes linked with PABPC4L. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibitor of mTOR, a regulator of protein synthesis; could possibly activate PABPC4L by altering the translation of proteins. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and could possibly activate PABPC4L by affecting intracellular transport and mRNA localization processes. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits transcription, which could possibly activate PABPC4L by altering mRNA synthesis and stability. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, which could possibly activate PABPC4L by affecting the translational machinery's association with mRNA. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, which could possibly activate PABPC4L by altering gene expression and potentially its own expression levels. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi function, which could possibly activate PABPC4L by having downstream effects on cellular signaling and protein synthesis. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor, which could possibly activate PABPC4L by leading to changes in chromatin structure and gene expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, which could possibly activate PABPC4L by impacting the cellular protein degradation pathway. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Causes premature chain termination during protein synthesis; could possibly activate PABPC4L by affecting overall protein synthesis. | ||||||